Yesway Announces Pricing of Initial Public Offering
FORT WORTH, Texas, April 21, 2026 /PRNewswire/ -- Yesway, Inc. ("Yesway") today announced the pricing of its initial public offering...
Read moreDetails
Press Releases
Georgia Heritage Financial Credit Union Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information
National class action firm offering free case evaluations to individuals impacted by the Georgia Heritage Financial Credit Union cybersecurity incident...
Read moreDetailsKemper Corporation Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information
National class action firm offering free case evaluations to individuals impacted by the Kemper Corporation cybersecurity incident NEWTOWN, Pa., April...
Read moreDetailsDayspring Pharma Announces Phase II Trial of CG2001 Foam Met Primary Endpoint in Chinese Adult Men with AGA
BEIJING, April 22, 2026 /PRNewswire/ -- Dayspring Pharma today announced top-line data from its Phase II clinical trial of CG2001 foam...
Read moreDetailsThe New Terminal One at JFK Welcomes Saudia as Newest Airline Partner Strengthening Connectivity with Saudi Arabia
NEW YORK, April 21, 2026 /PRNewswire/ -- The New Terminal One at New York John F. Kennedy International Airport will...
Read moreDetailsTarget Hospitality Announces Pricing of Secondary Offering
THE WOODLANDS, Texas, April 21, 2026 /PRNewswire/ -- Target Hospitality Corp. ("Target Hospitality" or the "Company") (Nasdaq: TH), one of...
Read moreDetails
Total Investment of Approx. USD 8.5 Million in Malaria and NTD R&D Projects With Partners Including MMV, GSK, Tanabe Pharma, Eisai and DNDi
TOKYO, April 22, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY...
Read moreDetails
Case Report of Mabwell’s Nectin-4 targeting ADC (9MW2821) in Cervical Cancer Published in The New England Journal of Medicine
SHANGHAI, April 21, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industrial chain, announced that...
Read moreDetails
Cooler Destinations, Hotter Demand: Travellers Seek ‘Coolcations’ as Temperatures Rise
Experts project that 2026 will likely be among the four hottest years on record, as climate change picks paceData shows...
Read moreDetailsRactigen Therapeutics Presents Positive Phase I Data for RAG-17 in SOD1-ALS at the 2026 AAN Annual Meeting, Demonstrating 81% Reduction in Neurofilament Light Chain
— Single intrathecal dose of SCAD-siRNA therapeutic RAG-17 yields favorable safety profile and profound, durable biomarker reductions —— Preliminary data...
Read moreDetails